166 related articles for article (PubMed ID: 1702493)
41. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
Martini N; Kris MG; Flehinger BJ; Gralla RJ; Bains MS; Burt ME; Heelan R; McCormack PM; Pisters KM; Rigas JR
Ann Thorac Surg; 1993 Jun; 55(6):1365-73; discussion 1373-4. PubMed ID: 8390230
[TBL] [Abstract][Full Text] [Related]
42. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Yamaguchi M; Fukuyama Y; Ichinose Y
Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
[TBL] [Abstract][Full Text] [Related]
43. [Assessment of a phase III trial of adjuvant chemotherapy in resected lung cancer: an imbalance of surgical results among cooperative institutions].
Ohta M; Hara N
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1511-5. PubMed ID: 1649582
[TBL] [Abstract][Full Text] [Related]
44. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Carles J; Rosell R; Ariza A; Pellicer I; Sanchez JJ; Fernandez-Vasalo G; Abad A; Barnadas A
Lung Cancer; 1993 Dec; 10(3-4):209-19. PubMed ID: 7521264
[TBL] [Abstract][Full Text] [Related]
45. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
Eur J Surg Oncol; 1995 Feb; 21(1):69-77. PubMed ID: 7851558
[TBL] [Abstract][Full Text] [Related]
46. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
[TBL] [Abstract][Full Text] [Related]
47. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304).
Tada H; Tsuchiya R; Ichinose Y; Koike T; Nishizawa N; Nagai K; Kato H
Lung Cancer; 2004 Feb; 43(2):167-73. PubMed ID: 14739037
[TBL] [Abstract][Full Text] [Related]
48. A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
Fukuoka M; Masuda N; Furuse K; Negoro S; Takada M; Matsui K; Takifuji N; Kudoh S; Kawahara M; Ogawara M
J Clin Oncol; 1991 Apr; 9(4):606-13. PubMed ID: 1648597
[TBL] [Abstract][Full Text] [Related]
49. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
Tejedor M; Valerdi JJ; López R; Domínguez MA; Arias F; Illarramendi JJ; Martínez E
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):813-8. PubMed ID: 7860393
[TBL] [Abstract][Full Text] [Related]
50. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Tanaka N; Inoue F; Takeda I; Mori T; Miyake M; Mimura H; Orita K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):59-66. PubMed ID: 2447836
[TBL] [Abstract][Full Text] [Related]
51. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
[TBL] [Abstract][Full Text] [Related]
52. Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence.
Sadeghi A; Payne D; Rubinstein L; Lad T
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):89-97. PubMed ID: 2839444
[TBL] [Abstract][Full Text] [Related]
53. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
Dediu M; Ion O; Ion R; Alexandru A; Median D; Gal C; Horvat T; Motas C; Motas N
J BUON; 2012; 17(2):317-22. PubMed ID: 22740212
[TBL] [Abstract][Full Text] [Related]
54. [Postoperative adjuvant treatment for non-small cell lung cancer].
Ichinose Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2470-4. PubMed ID: 12506468
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Wada H; Hitomi S; Teramatsu T
J Clin Oncol; 1996 Apr; 14(4):1048-54. PubMed ID: 8648356
[TBL] [Abstract][Full Text] [Related]
56. The comparison of CAP chemotherapy and radiotherapy to radiotherapy alone for resected lung cancer with positive margin or involved highest sampled paratracheal node (stage IIIA). LCSG 791.
Lad T
Chest; 1994 Dec; 106(6 Suppl):302S-306S. PubMed ID: 7988249
[TBL] [Abstract][Full Text] [Related]
57. ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Ozdemir O; Ozdemir P; Veral A; Uluer H; Ozhan MH
Asian Pac J Cancer Prev; 2013; 14(8):4679-83. PubMed ID: 24083725
[TBL] [Abstract][Full Text] [Related]
58. [Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy].
Takashi M; Murase T; Aota Y; Nagai T; Kinjo T; Sabashi M; Shimoji T; Miyake K; Hamajma N; Mizuno S
Hinyokika Kiyo; 1988 Aug; 34(8):1377-81. PubMed ID: 2461643
[TBL] [Abstract][Full Text] [Related]
59. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma.
Holmes EC
Chest; 1994 Dec; 106(6 Suppl):293S-296S. PubMed ID: 7988247
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
